Skip to main content

Harmony Biosciences Holdings, Inc.

HRMY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001802665

In the last 90 days, Harmony Biosciences Holdings, Inc. insiders filed 0 open-market purchases and 2 sales; 328 institutions reported holding it in 13F filings for Q2 2026, worth $1.97B in total; no superinvestor holds it.

Superinvestors holding HRMY, Q2 2026

See all superinvestors

No superinvestor reported holding HRMY in Q2 2026.